BioNTech


Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Support The Post Millennial
3 months ago

BREAKING: Pfizer and BioNTech to submit emergency use authorization request for COVID-19 vaccine to FDA

Pfizer and Biotech said in a statement that they hope to see their vaccine be potentially available by mid-to-late December.

Roberto Wakerell-Cruz
3 months ago

COVID-19 vaccine 95% successful—could shortly be available for emergency use

Pfizer and BioNTech have developed and recently tested BNT162b2—a COVID-19 vaccine which has been found to be over 95 percent successful in preventing the virus through multiple trials.

Leonardo Briceno
Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Support The Post Millennial